|
MBD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.363200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.446010E-04 |
| Normal-vs-Stage2 |
4.012100E-02 |
| Normal-vs-Stage3 |
7.559600E-01 |
| Normal-vs-Stage4 |
7.444400E-01 |
| Stage1-vs-Stage2 |
6.209800E-01 |
| Stage1-vs-Stage3 |
6.401900E-02 |
| Stage1-vs-Stage4 |
2.997000E-01 |
| Stage2-vs-Stage3 |
2.345800E-01 |
| Stage2-vs-Stage4 |
4.359200E-01 |
| Stage3-vs-Stage4 |
8.864000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.521300E-03 |
| Normal-vs-AfricanAmerican |
1.439850E-03 |
| Normal-vs-Asian |
7.544400E-01 |
| Caucasian-vs-AfricanAmerican |
2.997800E-01 |
| Caucasian-vs-Asian |
2.932000E-01 |
| AfricanAmerican-vs-Asian |
1.642570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.698190E-03 |
| Normal-vs-Female |
6.849900E-04 |
| Male-vs-Female |
2.625400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.658400E-02 |
| Normal-vs-Extreme_Weight |
9.903300E-03 |
| Normal-vs-Obese |
8.984900E-03 |
| Normal-vs-Extreme_Obese |
5.686400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.814600E-01 |
| Normal_Weight-vs-Obese |
7.599400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.334800E-01 |
| Extreme_Weight-vs-Obese |
8.580800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.843400E-01 |
| Obese-vs-Extreme_Obese |
5.114800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.625830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.58682999999993E-05 |
| Normal-vs-Age(61-80Yrs) |
5.605600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.587800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.277600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.675400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.103200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.221300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.020200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.098800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.42229999947163E-07 |
| Normal-VS-Type2 PRCC |
3.628200E-01 |
| Normal-VS-KIRP CIMP |
1.775870E-02 |
| Normal-VS-Unclassified PRCC |
1.276560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.07400000004532E-07 |
| Type1 PRCC-VS-KIRP CIMP |
6.146400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.313650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.507600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.248300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.084600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.472800E-01 |
| Normal-vs-N1 |
6.019200E-01 |
| Normal-vs-N2 |
3.046400E-01 |
| N0-vs-N1 |
8.487600E-01 |
| N0-vs-N2 |
4.089000E-01 |
| N1-vs-N2 |
4.423600E-01 |
|
|
